CovalX New Chairman of the Board

CovalX would like to first congratulate and thank Philip Bodmer, for over 15 years of successful leadership as the CovalX Chairman of the Board. Your guidance has proven invaluable to CovalX for its continuous development throughout the years. Your oversight has helped CovalX stay competitive in the market and grow into a respected company.

CovalX would like to congratulate and welcome René Lenggenhager Ph.D for his appointment as the Chairman of the Board at CovalX AG. René has significant experience in business management of scientific instrumentation and services. We look forward to his expertise both in business and scientifically to further help CovalX navigate our future of further growth. Our whole team at CovalX is excited for your new guidance and leadership.

Dr. René Lenggenhager was appointed as Chairman of the CovalX Board of Directors, effective June 22nd, 2022. He has been a member of the CovalX board of directors for one year. He was previously CEO of Comet AG, a publicly listed company on the Swiss Stock Exchange, which is a global leader in high-tech components for radio and x-ray. Prior to Comet, Dr. Lenggenhager was Group President of Bruker BioSpin and General Manager of Mettler-Toledo; both positions in the area of advanced analytical tools.

Mr. Lenggenhagger has worked with several innovative Swiss start-up companies and has formal training and experience as a Board Member in Switzerland. He was originally educated as an Electrical Engineer before completing his Dr. sc. Nat. at the ETH in Zurich. He then obtained an MBA from the University of St. Gallen and advanced training at INSEAD in Fontainebleau. His expertise includes not only extensive knowledge of scientific instrumentation and management but also scientific services; all of which could be of direct benefit towards CovalX development plans.


CovalX AG was founded in 2005 and is headquartered in Zurich, Switzerland with the vision to become the leading provider of technology and services in the field of High-Mass MALDI analysis for intact proteins and protein interactions. With support offices in Europe, North America and Asia, CovalX is a global company offering leading product and services for major pharmaceutical companies, as well as academic laboratories worldwide. CovalX is a fast-growing company, developing innovative analysis solutions for the characterization of therapeutic proteins and protein interactions in the life science industry.